Global Extracellular Vesicle Therapy Market Growth (Status and Outlook) 2024-2030

The global Extracellular Vesicle Therapy market size is predicted to grow from US$ 884 million in 2024 to US$ 1636 million in 2030; it is expected to grow at a CAGR of 10.8% from 2024 to 2030.

Extracellular Vesicle Therapy refers to an emerging therapy that uses extracellular vesicles as a therapeutic approach. These extracellular vesicles are small vesicles released by cells that can carry a variety of biological molecules (such as proteins, lipids, and RNA) to transmit signals and exchange substances between cells.

United States market for Extracellular Vesicle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Extracellular Vesicle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Extracellular Vesicle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Extracellular Vesicle Therapy players cover FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information)' newest research report, the “Extracellular Vesicle Therapy Industry Forecast” looks at past sales and reviews total world Extracellular Vesicle Therapy sales in 2023, providing a comprehensive analysis by region and market sector of projected Extracellular Vesicle Therapy sales for 2024 through 2030. With Extracellular Vesicle Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracellular Vesicle Therapy industry.

This Insight Report provides a comprehensive analysis of the global Extracellular Vesicle Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Extracellular Vesicle Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Extracellular Vesicle Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracellular Vesicle Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracellular Vesicle Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Extracellular Vesicle Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
Exosome-based
Microvesicle-based

Segmentation by Application:
Cancer Treatment
Regenerative Medicine
Drug Delivery
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
FUJIFILM Diosynth Biotechnologies
EV Therapeutics
Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO

Please note: The report will take approximately 2 business days to prepare and deliver.